Calcium N5-methyltetrahydrofolate
CAS No. 26560-38-3
Calcium N5-methyltetrahydrofolate( NSC-173328 )
Catalog No. M13814 CAS No. 26560-38-3
The calcium salt of levomefolic acid that has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 87 | Get Quote |
|
| 5MG | 161 | Get Quote |
|
| 10MG | 260 | Get Quote |
|
| 25MG | 494 | Get Quote |
|
| 50MG | 716 | Get Quote |
|
| 100MG | 981 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCalcium N5-methyltetrahydrofolate
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe calcium salt of levomefolic acid that has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers.
-
DescriptionThe calcium salt of levomefolic acid that has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC-173328
-
PathwayCell Cycle/DNA Damage
-
TargetAntifolate
-
RecptorAntifolate
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number26560-38-3
-
Formula Weight497.5179
-
Molecular FormulaC20H23CaN7O6
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(O)CC[C@@H](C([O-])=O)NC(C1=CC=C(NCC2N(C)C3=C(NC(N)=NC3=O)NC2)C=C1)=O.[Ca+2]
-
Chemical NameL-Glutamic acid, N-[4-[[(2-amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-, calcium salt (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Levomefolate calcium
A calcium salt of levomefolic acid.
-
Farletuzumab
Farletuzumab (MORAb-003) is a humanized monoclonal antibody with a high affinity for folate receptor-α (FRα), acting as a potent inhibitor of FRα and impeding the growth of cells that overexpress this receptor, making it useful for cancer research.
-
Mirvetuximab
Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1).
Cart
sales@molnova.com